JillGilbertMD

Clinical Trials

• Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer Start of enrollment: 2004 Aug 01

  Terminated

  Phase 3

• Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08

  Active, not recruiting

  Phase 3

• Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Start of enrollment: 2009 Mar 16

  Completed

  Phase 2

• Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01

  Terminated

  Phase 2

• Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer Start of enrollment: 2010 Sep 09

  Completed

  Phase 1, Phase 2

• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2012 Feb 01

  Completed

  Phase 2

• A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2012 Nov 12

  Terminated

  Phase 1, Phase 2

• Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Head and Neck Carcinoma (CheckMate 141) Start of enrollment: 2014 May 29

  Completed

  Phase 3

• Join now to see all